Divi’s Laboratories shares are top Indian Pharma pick for Citi

Brokerage firm Citi mentioned that Divi’s Laboratories is well-positioned from a tactical as well as a structural point of view.

Leave a Reply

Your email address will not be published. Required fields are marked *